FDA NDC Directory · JSON-LD · Markdown

Sulindac

NDC 0591-5660 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA071795
Dosage form / routeTABLET · ORAL
Active ingredientsSULINDAC (200 mg/1)
Marketing started19900403
Package count2

External sources

Source: openFDA. Public-domain (CC0).